Lialda Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase
Condition:   Ulcerative ColitisInterventions:   Drug: Mesalazine Enema;   Drug: Placebo EnemaSponsor:   Ferring PharmaceuticalsRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2015 Category: Research Source Type: clinical trials

An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase
Condition:   Ulcerative ColitisInterventions:   Drug: Mesalazine Enema;   Drug: Placebo EnemaSponsor:   Ferring PharmaceuticalsRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2015 Category: Research Source Type: clinical trials

Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment
Condition:   Ulcerative ColitisIntervention:   Drug: mesalazineSponsor:   Ferring PharmaceuticalsNot yet recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2014 Category: Research Source Type: clinical trials

Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment
Condition:   Ulcerative ColitisIntervention:   Drug: mesalazineSponsor:   Ferring PharmaceuticalsNot yet recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 7, 2014 Category: Research Source Type: clinical trials